Literature DB >> 7641960

History of ergot alkaloids from ergotism to ergometrine.

P W van Dongen1, A N de Groot.   

Abstract

Epidemics of ergotism occurred frequently in the Middle Ages. They were a source of inspiration for artists and were popularly known as 'St. Anthony's Fire', resulting in gangrene, neurological diseases and death. It was caused by eating rye bread contaminated with the fungus claviceps purpurea. In 1582 it was described that a delivery could be hastened by administering a few spurs of the secale cornutum. The dosage was, however, very inaccurate resulting in frequent uterine ruptures. The nickname of the preparation of 'pulvis ad partum' was changed to 'pulvis ad mortem'. Therefore, after 1828 the ergot alkaloids were no longer used during delivery but only as a measure to prevent postpartum haemorrhage. From 1875 onwards many derivatives of ergot alkaloids were found. Dudley and Moir isolated ergometrine in 1932. It proved to have a very specific uterotonic action. However, because of severe and unpredictable side effects and the instability of the drug, ergometrine is not the drug of choice for either the prevention or the treatment of postpartum haemorrhage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641960     DOI: 10.1016/0028-2243(95)02104-z

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  15 in total

Review 1.  Bioactive cyclobutane-containing alkaloids.

Authors:  Valery M Dembitsky
Journal:  J Nat Med       Date:  2007-09-05       Impact factor: 2.343

2.  Development of a UHPLC-FLD method for the analysis of ergot alkaloids and application to different types of cereals from Luxembourg.

Authors:  Claude Schummer; Loïc Brune; Gilbert Moris
Journal:  Mycotoxin Res       Date:  2018-08-16       Impact factor: 3.833

3.  Application of Liquid Chromatography/Ion Trap Mass Spectrometry Technique to Determine Ergot Alkaloids in Grain Products.

Authors:  Marcin Bryła; Krystyna Szymczyk; Renata Jędrzejczak; Marek Roszko
Journal:  Food Technol Biotechnol       Date:  2015-03       Impact factor: 3.918

Review 4.  Astonishing diversity of natural surfactants: 6. Biologically active marine and terrestrial alkaloid glycosides.

Authors:  Valery M Dembitsky
Journal:  Lipids       Date:  2005-11       Impact factor: 1.880

Review 5.  Ergot Alkaloids of the Family Clavicipitaceae.

Authors:  Simona Florea; Daniel G Panaccione; Christopher L Schardl
Journal:  Phytopathology       Date:  2017-03-29       Impact factor: 4.025

6.  The structure of dimethylallyl tryptophan synthase reveals a common architecture of aromatic prenyltransferases in fungi and bacteria.

Authors:  Ute Metzger; Christoph Schall; Georg Zocher; Inge Unsöld; Edyta Stec; Shu-Ming Li; Lutz Heide; Thilo Stehle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

Review 7.  Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology.

Authors:  A N de Groot; P W van Dongen; T B Vree; Y A Hekster; J van Roosmalen
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

Review 8.  A bibliometric review of drug repurposing.

Authors:  Nancy C Baker; Sean Ekins; Antony J Williams; Alexander Tropsha
Journal:  Drug Discov Today       Date:  2018-01-09       Impact factor: 7.851

9.  Determination of the Main Ergot Alkaloids and Their Epimers in Oat-Based Functional Foods by Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry.

Authors:  Laura Carbonell-Rozas; Laura Gámiz-Gracia; Francisco J Lara; Ana M García-Campaña
Journal:  Molecules       Date:  2021-06-18       Impact factor: 4.411

10.  Aptamer-based molecular recognition of lysergamine, metergoline and small ergot alkaloids.

Authors:  Elsa Rouah-Martin; Jaytry Mehta; Bieke van Dorst; Sarah de Saeger; Peter Dubruel; Bert U W Maes; Filip Lemiere; Erik Goormaghtigh; Devin Daems; Wouter Herrebout; François van Hove; Ronny Blust; Johan Robbens
Journal:  Int J Mol Sci       Date:  2012-12-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.